Division of AstraZeneca PLC
Latest From Definiens AG
While other venture capitalists are curbing their efforts in medtech, Wellington Partners intends to maintain its support for the sector earmarking about half of its new €210m WPLS-V fund for European medtech opportunities.
With its WPLS-IV fund now fully committed, Wellington Partners has returned to the market and raised €210m in its WPLS-V fund which will focus on European biotech and medtech opportunities.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
- In Vitro Diagnostics
Laboratory Testing Services
- Anatomical Pathology
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- AstraZeneca PLC
- Senior Management
Thomas P Heydler, CEO
Markus Rinecker, MD, CFO
Christiaan Neeleman, COO
Ralf Huss, MD, CMO
Michael Rasche, SVP, Global Sales
- Contact Info
Phone: (49) 89 231180 0
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.